{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T03:00:03Z","timestamp":1648782003968},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mod Rheumatol"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1007\/s10165-009-0176-y","type":"journal-article","created":{"date-parts":[[2009,5,18]],"date-time":"2009-05-18T08:58:15Z","timestamp":1242637095000},"page":"416-419","source":"Crossref","is-referenced-by-count":3,"title":["Sj\u00f6gren\u2019s syndrome patients presenting with hypergammaglobulinemia are relatively unresponsive to cevimeline treatment"],"prefix":"10.1093","volume":"19","author":[{"given":"Koichiro","family":"Komai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuko","family":"Shiozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Yoshihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Yamane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Murata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Tsumiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Hashiramoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichi","family":"Shiozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,5,19]]},"reference":[{"issue":"5","key":"176_CR1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/ncprheum0165","volume":"2","author":"CP Mavragani","year":"2006","unstructured":"Mavragani CP, Moutsopoulos NM, Moutsopoulos HM. The management of Sj\u00f6gren\u2019s syndrome. Nat Clin Pract Rheumatol. 2006;2(5):252\u201361.","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"Pt B","key":"176_CR2","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/978-1-4615-0717-8_53","volume":"506","author":"RI Fox","year":"2002","unstructured":"Fox RI. Use of cevimeline, a muscarinic M1 and M3 agonist, in the treatment of Sj\u00f6gren\u2019s syndrome. Adv Exp Med Biol. 2002;506(Pt B):1107\u201316.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"176_CR3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0306-3623(94)90021-3","volume":"25","author":"Y Iwabuchi","year":"1994","unstructured":"Iwabuchi Y, Masuhara T. Sialogogic activities of SNI-2011 compared with those of pilocarpine and McN-A-343 in rat salivary glands: identification of a potential therapeutic agent for treatment of Sj\u00f6rgen\u2019s syndrome. Gen Pharmacol. 1994;25(1):123\u20139.","journal-title":"Gen Pharmacol"},{"issue":"11","key":"176_CR4","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1001\/archinte.162.11.1293","volume":"162","author":"RS Fife","year":"2002","unstructured":"Fife RS, Chase WF, Dore RK, Wiesenhutter CW, Lockhart PB, Tindall E, et al. Cevimeline for the treatment of xerostomia in patients with Sj\u00f6gren syndrome: a randomized trial. Arch Intern Med. 2002;162(11):1293\u2013300.","journal-title":"Arch Intern Med"},{"issue":"1","key":"176_CR5","first-page":"48","volume":"40","author":"S Miyawaki","year":"2000","unstructured":"Miyawaki S. Revised Japan criteria for Sj\u00f6gren syndrome. Ryumachi. 2000;40(1):48\u201353.","journal-title":"Ryumachi"},{"issue":"10","key":"176_CR6","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/art.1780281008","volume":"28","author":"PF Kohler","year":"1985","unstructured":"Kohler PF, Winter ME. A quantitative test for xerostomia. The Saxon test, an oral equivalent of the Schirmer test. Arthritis Rheum. 1985;28(10):1128\u201332.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"176_CR7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2165\/00063030-200013050-00001","volume":"13","author":"S Shiozawa","year":"2000","unstructured":"Shiozawa S, Cummins JM, Fox PC. Opening the flood gates: interferon-alpha treatment for Sj\u00f6gren\u2019s syndrome. BioDrugs. 2000;13(5):305\u201311.","journal-title":"BioDrugs"},{"issue":"5","key":"176_CR8","first-page":"953","volume":"3","author":"T D\u00f6rner","year":"2007","unstructured":"D\u00f6rner T, Goldenberg DM. Targeting CD22 as a strategy for treating systemic autoimmune diseases. Ther Clin Risk Manag. 2007;3(5):953\u20139.","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"176_CR9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1053\/sarh.2003.50019","volume":"33","author":"P Manganelli","year":"2003","unstructured":"Manganelli P, Fietta P. Apoptosis and Sj\u00f6gren syndrome. Semin Arthritis Rheum. 2003;33(1):49\u201365.","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"176_CR10","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1046\/j.1365-2249.1996.42748.x","volume":"104","author":"S Bacman","year":"1996","unstructured":"Bacman S, Sterin-Borda L, Camusso JJ, Arana R, Hubscher O, Borda E. Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sj\u00f6gren\u2019s syndrome. Clin Exp Immunol. 1996;104(3):454\u20139.","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"176_CR11","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/art.21764","volume":"54","author":"LJ Dawson","year":"2006","unstructured":"Dawson LJ, Stanbury J, Venn N, Hasdimir B, Rogers SN, Smith PM. Antimuscarinic antibodies in primary Sj\u00f6gren\u2019s syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells. Arthritis Rheum. 2006;54(4):1165\u201373.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"176_CR12","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1089\/jir.1995.15.759","volume":"15","author":"N Ogawa","year":"1995","unstructured":"Ogawa N, Dang H, Lazaridis K, McGuff HS, Aufdemorte TB, Talal N. Analysis of transforming growth factor beta and other cytokines in autoimmune exocrinopathy (Sj\u00f6gren\u2019s syndrome). J Interferon Cytokine Res. 1995;15(9):759\u201367.","journal-title":"J Interferon Cytokine Res"},{"issue":"1","key":"176_CR13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1006\/clim.2002.5228","volume":"104","author":"A Berra","year":"2002","unstructured":"Berra A, Sterin-Borda L, Bacman S, Borda E. Role of salivary IgA in the pathogenesis of Sj\u00f6gren syndrome. Clin Immunol. 2002;104(1):49\u201357.","journal-title":"Clin Immunol"},{"issue":"4","key":"176_CR14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1089\/jir.1998.18.255","volume":"18","author":"S Shiozawa","year":"1998","unstructured":"Shiozawa S, Tanaka Y, Shiozawa K. Single-blinded controlled trial of low-dose oral IFN-alpha for the treatment of xerostomia in patients with Sj\u00f6gren\u2019s syndrome. J Interferon Cytokine Res. 1998;18(4):255\u201362.","journal-title":"J Interferon Cytokine Res"},{"issue":"11","key":"176_CR15","first-page":"5527","volume":"158","author":"T Nakabayashi","year":"1997","unstructured":"Nakabayashi T, Letterio JJ, Geiser AG, Kong L, Ogawa N, Zhao W, et al. Up-regulation of cytokine mRNA, adhesion molecule proteins, and MHC class II proteins in salivary glands of TGF-beta1 knockout mice: MHC class II is a factor in the pathogenesis of TGF-beta1 knockout mice. J Immunol. 1997;158(11):5527\u201335.","journal-title":"J Immunol"},{"issue":"7","key":"176_CR16","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1002\/art.21945","volume":"54","author":"MV Jonsson","year":"2006","unstructured":"Jonsson MV, Delaleu N, Brokstad KA, Berggreen E, Skarstein K. Impaired salivary gland function in NOD mice: association with changes in cytokine profile but not with histopathologic changes in the salivary gland. Arthritis Rheum. 2006;54(7):2300\u20135.","journal-title":"Arthritis Rheum"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10165-009-0176-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T16:27:15Z","timestamp":1646843235000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10165-009-0176-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,19]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["176"],"URL":"https:\/\/doi.org\/10.1007\/s10165-009-0176-y","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,19]]}}}